ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 13, 2017
A Guide to Using Valuentum's Stock Reports
There is no better value in investment research and analysis. Period. Within the individual premium plan, we offer two newsletters (the Best Ideas Newsletter, Dividend Growth Newsletter), delivered by email. On the website, we provide hundreds of stock and dividend reports, proprietary metrics such as the Dividend Cushion ratio, fair value estimates, Valuentum Buying Index ratings, commentary and analysis, weekly screens, plus access to the Valuentum team and much more. As a member, learn more about Valuentum's stock reports by downloading the guide here (pdf). Thank you!
Nov 11, 2017
4 Burning Questions About Gilead Sciences
Image Source: Gilead. We were pleased with the jump in shares of Gilead Sciences following its recent addition to the newsletter portfolios. The equity has given back some of those gains more recently as questions have resurfaced on the vitality of the enterprise. In this article, we work through the top 4 questions for readers to consider in evaluating Gilead Sciences.
Nov 10, 2017
Could Sally Beauty Become Amazon’s “Whole Foods” Foray into Beauty Supply?
Image Source: Sally Beauty.  “The Amazon Effect” on traditional retail is not a new development, but there are some pockets of retail that were believed to be impenetrable by the e-commerce giant. We’re beginning to see that such a notion may have been nothing short of wishful thinking.
Nov 10, 2017
Qualcomm Surges to Fair Value on Broadcom Offer
Shares of Qualcomm have faced meaningful pressure for the majority of 2017 as it deals with a legal battle with Apple, but the stock has rallied after Broadcom offered the firm a deal worth $70 per share in cash and stock.
Nov 10, 2017
Dividend Increases/Decreases for the Week Ending November 10
Let's take a look at companies raising/lowering their dividends this week.
Nov 8, 2017
Alphabet Soars to New Highs, Priceline Tumbles
Image shown: Alphabet’s shares have been surging higher, and we think the move is justified on the basis of our fair value estimate. Best Ideas Newsletter portfolio idea Alphabet continues to drive tremendous fundamental performance via its strength in search, and its pipeline of new opportunities may offer another blockbuster product in the years ahead. Priceline, on the other hand, has been under selling pressure following a disappointing bottom-line outlook for the fourth quarter.
Nov 7, 2017
Michael Kors’ Stock Surges; Market Overreacts to Hanesbrands' Results
Image shown: Shares of Michael Kors have been rocketing higher recently. The stock is rated 9 on the Valuentum Buying Index. The sole 9 rating on the Valuentum Buying Index has had a very nice couple of months recently. Meanwhile, Hanesbrands is feeling the wrath of considerable selling pressure, and we don't think it is justified.
Nov 7, 2017
Analysis of Spark Energy (SPKE) and Brighthouse Financial (BHF)
Let's talk about an extremely risky microcap energy equity and a unique potential value opportunity in the insurance industry, Brighthouse Financial, the spinoff of Metlife.
Nov 3, 2017
Dividend Increases/Decreases for the Week Ending November 3
Let's take a look at companies raising/lowering their dividends this week.
Nov 3, 2017
Add the New High Yield Dividend Newsletter! It’s Purely Incremental
The Dividend Growth Newsletter is part of a premium, adviser, or institutional membership to Valuentum, but the new High Yield Dividend Newsletter is purely incremental. Add it to any membership today! Update: The $400/year offer for the High Yield Dividend Newsletter has passed, but you can still sign up for $500/year before the end of the year ($1,000/year thereafter). Lock in the savings!


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.